{"url_path":"/sec/uncy/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-054708-index.html","accession_number":"0001213900-26-054708","cik":"0001766140","ticker":"UNCY","issuer_name":"Unicycive Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-054708-index.html","primary_entity_key":"0001766140","primary_entity_name":"Unicycive Therapeutics, Inc."},"word_count":449,"has_tables":true,"body_markdown":"**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n \n\n**FORM 10-Q**\n\n \n\n☒ **QUARTERLY REPORT PURSUANT TO SECTION\n13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n** **\n\n**For the quarterly period ended March 31, 2026**\n\n \n\n**OR**\n\n \n\n☐ **TRANSITION REPORT PURSUANT TO SECTION\n13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the transition period from ____ to ____**\n\n \n\n**Commission file number: 001-40582**\n\n \n\n**UNICYCIVE THERAPEUTICS, INC.**\n\n*(Exact name of Registrant as specified in its\ncharter)*\n\n \n\n**Delaware**   **2834**   **81-3638692**\n\n(State or other jurisdiction of\nincorporation or organization)   (Primary Standard Industrial\nClassification Code Number)   (I.R.S. Employer\nIdentification Number)\n\n \n\n**1975 W. El Camino Real, Suite 204**\n\n**Mountain View, CA 94040**\n\n**(650) 351-4495**\n\n*(Address and telephone number of principal\nexecutive offices)*\n\n \n\n \n\n*(Former name, former address, and former fiscal\nyear, if changed since last report)*\n\n \n\nIndicate by check mark whether the registrant:\n(1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding\n12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing\nrequirements for the past 90 days. ☒ Yes ☐ No\n\n \n\nIndicate by check mark whether the registrant\nhas submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405\nof this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒\nYes ☐ No\n\n \n\nIndicate by check mark whether the registrant\nis a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.\nSee the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”,\nand “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐\n\nNon-accelerated filer ☒ Smaller reporting company ☒\n\n  Emerging growth company ☒\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act ☐\n\n \n\nIndicate by check mark whether the registrant\nis a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No\n\n \n\nSecurities registered pursuant to Section 12(b)\nof the Act:\n\n \n\nTitle of each class   Trading Symbol(s)   Name of each exchange on which registered\n\nCommon Stock, par value $0.001 per share   UNCY   The NASDAQ Stock Market, LLC\n\n \n\nAs of May 12, 2026, there were 26,700,027 shares of the Company’s\ncommon stock, par value $0.001 per share, issued and outstanding.\n\n \n\n \n\n \n\n \n\n \n\n \n\n**TABLE OF CONTENTS**\n\n \n\n \n \n \n**Page\nNo.**\n\n[PART\nI – FINANCIAL INFORMATION](#a_001)"}